What is Tuune?
Tuune is a pioneering personalized women's healthcare company dedicated to enhancing the management of hormonal conditions. Leveraging state-of-the-art clinical decision support software, Tuune integrates evidence-based health science to evaluate up to 70 conditions, thereby improving women's overall well-being. The company's proprietary algorithm, developed by medical professionals, is designed to deliver tailored treatment plans, aiming to elevate patient outcomes and optimize physician efficiency. Tuune's services are specifically tailored for healthcare providers seeking to implement personalized care with greater effectiveness and speed.
How much funding has Tuune raised?
Tuune has raised a total of $4.6M across 1 funding round:
Unspecified
$4.6M
Unspecified (2021): $4.6M with participation from Octopus Ventures
Key Investors in Tuune
Octopus Ventures
Octopus Ventures is a founder-focused venture capital firm that backs mission-driven companies across various sectors, including health technology, offering long-term capital and strategic guidance.
What's next for Tuune?
The recent major strategic investment signals a pivotal growth phase for Tuune, likely enabling the company to scale its operations, further develop its AI-driven clinical decision support software, and expand its reach within the healthcare provider market. This capital infusion is expected to accelerate Tuune's mission to revolutionize women's hormonal health management, positioning it for significant advancements in personalized medicine and patient care.
See full Tuune company page
